Preconditioning of the ischaemic myocardium; involvement of the l‐arginine nitric oxide pathway

British Journal of Pharmacology

Volumn 107, Issue 3, 1992, Pages 648-652

  Vegh, Agnes ^a   Szekeres, Laszlo ^a   Parratt, James ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

endogenous myocardial protective substances; inhomogeneity of conduction; myocardial ischaemia; NG nitro l arginine methyl ester (l NAME); Nitric oxide; preconditioning; reperfusion; ventricular arrhythmias

Indexed keywords

N(G) NITROARGININE METHYL ESTER;

ARTICLE; BLOOD PRESSURE; CONDITIONING; CONTROLLED STUDY; DOG; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION;

ANIMAL; ARGININE; ARRHYTHMIA; BLOOD PRESSURE; DOGS; FEMALE; HEART RATE; HEMODYNAMICS; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; SUPPORT, NON-U.S. GOV'T;

EID: 0026801464     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1992.tb14501.x     Document Type: Article

References (23)

1. Effect of carbachol and cyclic GMP on susceptibility to ventricular fibrillation
2. Relationships between the severity of myocardial ischaemia, reperfusion‐induced ventricular fibrillation, and the late administration of dazmegrel and nifedipine
3. Influence of repetitive coronary occlusions on myocardial adenine nucleosides, high energy phosphates and ultrastructure
4. Preconditioning reduces the severity of ischaemia and reperfusion‐induced arrhythmias in both anaesthetised rats and dogs
5. Myocardial protection with preconditioning
6. 1 adenosine receptors in rabbit heart
7. Reduction of infarct size by local angiotensin‐converting enzyme inhibition is abolished by a bradykinin antagonist
8. G‐nitro arginine (l‐NOARG), a novel l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilation in vitro
9. Preconditioning with ischemia; a delay of lethal cell injury in ischemic myocardium
10. Role of cyclic nucleotides in heart metabolism
11. Reperfusion arrhythmias, platelet‐vessel wall interactions and endogenous antiarrhythmic substances
12. 2+‐independent nitric oxide synthase in the myocardium
13. Preconditioning of ischemic myocardium; reperfusion‐induced arrhythmias
14. The natural history of preconditioning, cardioprotection depends on duration of transient ischaemia and time to subsequent ischaemia
15. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats
16. Protective effects of preconditioning of the ischaemic myocardium involve cyclo‐oxygenase products
17. Transient ischaemia induced by rapid cardiac pacing results in myocardial preconditioning
18. Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia‐induced arrhythmias in anaesthetised dogs
19. Does nitric oxide play a role in ischaemic preconditioning?
20. Preconditioning, an early protective response to myocardial ischaemia
21. Nitric oxide involvement in preconditioning of the ischaemic myocardium in anaesthetised dogs
22. Preconditioning of the ischaemic myocardium is reversed by methylene blue; further evidence for the role of cGMP.
23. Effects of the blood supply to the normal non‐infarcted myocardium on the incidence and severity of early post‐occlusion arrhythmias in dogs